The compound is commonly investigated in biochemical research for its interaction with signalling mechanisms and peptide-mediated regulatory processes
BPC-157 is a synthetic pentadecapeptide derived from a protein fragment originally identified within gastric juice
Pharmacokinetics in patients with impaired hepatic function study design, data analysis and impact on dosing and labeling
Earlier oral trial METAOD005 randomized 300 adults with obesity to oral AOD-9604 (1, 5, 10, 20, or 30 mg/day) or placebo for 12 weeks
Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
It absorbs nutrients better and sends fewer inflammatory signals throughout the body